Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks.

Hyaluronic acid (HA) was derivatized with methacrylic esters used for the preparation of hydrogels via photopolymerization. Poly(ethylene glycol) diacrylate (PEG-DA) with a molecular weight of 570 was also used as a comacromonomer to improve elastic modulus and swelling behavior. The hydrogels were readily degraded by hyaluronidase and their mechanical properties could be modulated by HA molecular weight and concentration of PEG-DA. The incorporation of RGD peptides allowed modulation of the HA properties from cell non-adhesive to adhesive. Human dermal fibroblasts were cultured on the RGD, RDG, and non-functionalized HA hydrogels for up to 7d, showing adhesion and proliferation only with incorporated RGD.

[1]  J. Hubbell,et al.  Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Balazs,et al.  Hylan gel biomaterial: dermal and immunologic compatibility. , 1993, Journal of biomedical materials research.

[3]  C. Soria,et al.  Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro , 1996, International journal of cancer.

[4]  M. Morra,et al.  Anti-adhesive surfaces through hyaluronan coatings. , 1997, Medical device technology.

[5]  M. Litt,et al.  Rheology of the vitreous body: part 3. Concentration of electrolytes, collagen and hyaluronic acid. , 1994, Biorheology.

[6]  G. Prestwich,et al.  Chemical modification of hyaluronic acid by carbodiimides. , 1991, Bioconjugate chemistry.

[7]  R. O’Keefe,et al.  Hyaluronic acid therapy. , 2000, Instructional course lectures.

[8]  G. Abatangelo,et al.  Functions of hyaluronan in wound repair , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[9]  E. Menzel,et al.  Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. , 1998, Cancer letters.

[10]  T. Laurent,et al.  The structure and function of hyaluronan: An overview. , 1996, Immunology and cell biology.

[11]  F. Schier,et al.  Hyaluronate, tetrachlorodecaoxide, and galactolipid prevent adhesions after implantation of Gore-Tex and dura mater into the abdominal wall in rats , 1999, Pediatric Surgery International.

[12]  G. Prestwich,et al.  Hyaluronate derivatives in drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.

[13]  J. Hubbell,et al.  Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. , 2001, Biomacromolecules.

[14]  Rogers Hj The structure and function of hyaluronate. , 1961 .

[15]  M Moras,et al.  Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. , 1993, Biomaterials.

[16]  Y. Ikada,et al.  Crosslinking of hyaluronic acid with water-soluble carbodiimide. , 1997, Journal of biomedical materials research.

[17]  V. Hentz,et al.  Polypeptide resurfacing method improves fibroblast's adhesion to hyaluronan strands. , 1999, Journal of biomedical materials research.

[18]  K. Nishinari,et al.  Viscoelasticity of hyaluronic acid with different molecular weights. , 1994, Biorheology.

[19]  E. Turley,et al.  HA receptors: Regulators of signalling to the cytoskeleton , 1996, Journal of cellular biochemistry.

[20]  G. Prestwich,et al.  Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[21]  E. Balazs,et al.  Clinical uses of hyaluronan. , 2007, Ciba Foundation symposium.

[22]  O. Wik,et al.  Rheology of hyaluronate. , 1987, Acta oto-laryngologica. Supplementum.

[23]  R Scapinelli,et al.  Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. , 2000, Journal of biomedical materials research.

[24]  P. Kincade,et al.  CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.

[25]  W. Hickerson,et al.  Beneficial actions of exogenous hyaluronic acid on wound healing. , 1991, Surgery.

[26]  E. Turley,et al.  Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. , 1993, The Journal of biological chemistry.

[27]  G. Turner,et al.  CD44 in inflammation and metastasis , 1997, Glycoconjugate Journal.

[28]  J. Hubbell,et al.  Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. , 2001, Bioconjugate chemistry.

[29]  D. Wen Intra-articular hyaluronic acid injections for knee osteoarthritis. , 2000, American family physician.

[30]  M. Radice,et al.  Semisynthetic resorbable materials from hyaluronan esterification. , 1998, Biomaterials.

[31]  Linshu Liu,et al.  An osteoconductive collagen/hyaluronate matrix for bone regeneration. , 1999, Biomaterials.